Published in PLoS Pathog on May 29, 2009
Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol (2010) 4.13
Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol (2011) 2.03
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med (2013) 1.88
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Host imprints on bacterial genomes--rapid, divergent evolution in individual patients. PLoS Pathog (2010) 1.54
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol (2011) 1.26
Parallel exploitation of diverse host nutrients enhances Salmonella virulence. PLoS Pathog (2013) 1.24
Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog (2012) 1.22
Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun (2010) 1.19
Transcriptome of swarming Proteus mirabilis. Infect Immun (2010) 1.19
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens (2013) 1.15
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells. PLoS Pathog (2013) 1.14
Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog (2013) 1.10
Genomic sequence analysis and characterization of Sneathia amnii sp. nov. BMC Genomics (2012) 1.07
Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07
High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol (2012) 1.01
Phenotypic diversity caused by differential RpoS activity among environmental Escherichia coli isolates. Appl Environ Microbiol (2011) 0.99
Unified theory of bacterial sialometabolism: how and why bacteria metabolize host sialic acids. ISRN Microbiol (2013) 0.99
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol (2011) 0.99
YjhS (NanS) is required for Escherichia coli to grow on 9-O-acetylated N-acetylneuraminic acid. J Bacteriol (2009) 0.98
An incomplete TCA cycle increases survival of Salmonella Typhimurium during infection of resting and activated murine macrophages. PLoS One (2010) 0.96
New insights into the bacterial fitness-associated mechanisms revealed by the characterization of large plasmids of an avian pathogenic E. coli. PLoS One (2012) 0.95
Transcriptome analysis of avian pathogenic Escherichia coli O1 in chicken serum reveals adaptive responses to systemic infection. Infect Immun (2011) 0.94
Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect Immun (2011) 0.91
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90
A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog (2013) 0.90
Commensal and Pathogenic Escherichia coli Metabolism in the Gut. Microbiol Spectr (2015) 0.90
Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog (2015) 0.89
The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli. Infect Immun (2014) 0.88
Bacterial catabolism of nonulosonic (sialic) acid and fitness in the gut. Gut Microbes (2010) 0.87
Nutrient-responsive regulation determines biodiversity in a colicin-mediated bacterial community. BMC Biol (2014) 0.87
Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLoS Pathog (2015) 0.86
Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis. MBio (2016) 0.85
Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol Spectr (2015) 0.85
Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. Infect Immun (2012) 0.85
Identification of Avian pathogenic Escherichia coli genes that are induced in vivo during infection in chickens. Appl Environ Microbiol (2012) 0.84
From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr Urol Rep (2013) 0.84
Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract. Infect Immun (2014) 0.84
Yersinia high pathogenicity island genes modify the Escherichia coli primary metabolome independently of siderophore production. J Proteome Res (2011) 0.83
Two-dimensional gel electrophoresis in bacterial proteomics. Protein Cell (2012) 0.83
Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine. Infect Immun (2012) 0.83
Measuring Escherichia coli Gene Expression during Human Urinary Tract Infections. Pathogens (2016) 0.82
Fitness, stress resistance, and extraintestinal virulence in Escherichia coli. Infect Immun (2013) 0.81
The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine. Front Cell Infect Microbiol (2016) 0.81
Metabolism and Fitness of Urinary Tract Pathogens. Microbiol Spectr (2015) 0.81
The gluconeogenesis pathway is involved in maintenance of enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. PLoS One (2014) 0.81
Niche-specific contribution to streptococcal virulence of a MalR-regulated carbohydrate binding protein. Mol Microbiol (2011) 0.80
Role of intracellular carbon metabolism pathways in Shigella flexneri virulence. Infect Immun (2014) 0.80
The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli. J Bacteriol (2016) 0.79
tkt1, located on a novel pathogenicity island, is prevalent in avian and human extraintestinal pathogenic Escherichia coli. BMC Microbiol (2012) 0.78
Fur is the master regulator of the extraintestinal pathogenic Escherichia coli response to serum. MBio (2014) 0.78
PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli. Infect Immun (2014) 0.78
Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection. Proc Natl Acad Sci U S A (2016) 0.78
Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies. Microbiol Mol Biol Rev (2016) 0.78
Identification of a High-Affinity Pyruvate Receptor in Escherichia coli. Sci Rep (2017) 0.78
Urinary Tract Infection: Pathogenesis and Outlook. Trends Mol Med (2016) 0.77
Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection. mSphere (2016) 0.77
Laminaria japonica Extract, an Inhibitor of Clavibater michiganense Subsp. Sepedonicum. PLoS One (2014) 0.77
Signature-tagged mutagenesis and co-infection studies demonstrate the importance of P fimbriae in a murine model of urinary tract infection. Pathog Dis (2015) 0.77
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
ArcA Controls Metabolism, Chemotaxis, and Motility Contributing to the Pathogenicity of Avian Pathogenic Escherichia coli. Infect Immun (2015) 0.77
Purine biosynthesis metabolically constrains intracellular survival of uropathogenic E. coli. Infect Immun (2016) 0.76
The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection. Oxid Med Cell Longev (2016) 0.76
Siderophore biosynthesis coordinately modulated the virulence-associated interactive metabolome of uropathogenic Escherichia coli and human urine. Sci Rep (2016) 0.76
DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli. BMC Microbiol (2017) 0.75
Genome-wide analysis of the response to nitric oxide in uropathogenic Escherichia coli CFT073. Microb Genom (2015) 0.75
Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract. Front Cell Infect Microbiol (2017) 0.75
Coordination of Metabolism and Virulence Factors Expression of Extraintestinal Pathogenic Escherichia coli Purified from Blood Cultures of Patients with Sepsis. Mol Cell Proteomics (2016) 0.75
Comparative analysis of LytS/LytTR-type histidine kinase/response regulator systems in γ-proteobacteria. PLoS One (2017) 0.75
An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections. Front Cell Infect Microbiol (2017) 0.75
Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics. Front Microbiol (2017) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Culture medium for enterobacteria. J Bacteriol (1974) 37.59
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Antibacterial resistance worldwide: causes, challenges and responses. Nat Med (2004) 10.46
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis (2008) 10.14
Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 5.06
Glucose and gluconate metabolism in an Escherichia coli mutant lacking phosphoglucose isomerase. J Bacteriol (1967) 4.99
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A (2004) 4.31
Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol (2000) 4.26
Effect of different nutritional conditions on the synthesis of tricarboxylic acid cycle enzymes. J Bacteriol (1967) 3.64
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04
Urologic diseases in America Project: analytical methods and principal findings. J Urol (2005) 2.87
Glucose and gluconate metabolism in a mutant of Escherichia coli lacking gluconate-6-phosphate dehydrase. J Bacteriol (1967) 2.62
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J Bacteriol (1998) 2.53
Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun (2008) 2.30
From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat Med (2007) 2.23
Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol (2002) 2.18
A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol (1997) 1.89
Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol (2008) 1.73
Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect Immun (2004) 1.68
Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine. Infect Immun (1999) 1.68
Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol (1996) 1.67
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem (2007) 1.64
New phosphoglucose isomerase mutants of Escherichia coli. J Bacteriol (1975) 1.63
pckA-deficient Mycobacterium bovis BCG shows attenuated virulence in mice and in macrophages. Microbiology (2003) 1.61
Isolation and characterization of Escherichia coli mutants defective in enzymes of glycolysis. Biochem Biophys Res Commun (1974) 1.60
Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli. Mol Biol Evol (2004) 1.59
Genetics of pentose-phosphate pathway enzymes of Escherichia coli K-12. Arch Microbiol (1995) 1.54
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50
Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun (2007) 1.48
Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol Microbiol (2003) 1.43
Control of gluconeogenic growth by pps and pck in Escherichia coli. J Bacteriol (1993) 1.43
The housekeeping dipeptide permease is the Escherichia coli heme transporter and functions with two optional peptide binding proteins. Proc Natl Acad Sci U S A (2006) 1.41
Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice. Infect Immun (2006) 1.40
Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infect Immun (2008) 1.36
Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (2006) 1.34
The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis. FEMS Microbiol Lett (2000) 1.32
In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect Immun (2006) 1.24
Mutants in glucose metabolism. Annu Rev Biochem (1986) 1.23
The use of 6-labeled glucose to assess futile cycling in Escherichia coli. J Biol Chem (1980) 1.20
L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium. Infect Immun (2007) 1.17
Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr Opin Microbiol (2005) 1.13
Sugar metabolism in transketolase mutants of Escherichia coli. J Bacteriol (1974) 1.13
Glycogen production by different Salmonella enterica serotypes: contribution of functional glgC to virulence, intestinal colonization and environmental survival. Microbiology (2005) 1.09
Why metabolic enzymes are essential or nonessential for growth of Escherichia coli K12 on glucose. Biochemistry (2007) 1.02
Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun (2008) 0.98
Phosphoenolpyruvate carboxykinase is an acid-induced, chromosomally encoded virulence factor in Agrobacterium tumefaciens. J Bacteriol (2005) 0.97
A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice. Infect Immun (2007) 0.92
Glucose metabolism in Escherichia coli and the effect of increased amount of aldolase. Biochemistry (1993) 0.92
A proposed model for the regulation of phosphofructokinase and fructose 1,6-bisphosphatase based on their reciprocal anomeric specificities. FEBS Lett (1977) 0.81
Computer simulation of the fructose bisphosphatase/phosphofructokinase couple in rat liver. Eur J Biochem (1979) 0.80
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56
Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50
The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun (2011) 1.41
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun (2004) 1.36
Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol (2009) 1.34
Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun (2005) 1.32
Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol (2006) 1.29
Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol (2008) 1.25
complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol (2007) 1.24
Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun (2002) 1.22
In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun (2002) 1.21
Transcriptome of swarming Proteus mirabilis. Infect Immun (2010) 1.19
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun (2003) 1.16
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells. PLoS Pathog (2013) 1.14
Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol (2002) 1.14
Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun (2006) 1.14
Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog (2013) 1.10
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10
Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis (2013) 1.09
The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol (2010) 1.09
Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol (2008) 1.08
A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol Microbiol (2008) 1.07
Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07
Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun (2004) 1.07
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun (2012) 1.06
Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J Bacteriol (2008) 1.04
Helicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane protein. Infect Immun (2006) 1.04
The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J Med Microbiol (2007) 1.04
Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04
Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun (2006) 1.03
The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol (2002) 1.03
Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun (2004) 1.03
Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun (2010) 1.01
PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect Immun (2008) 1.00
The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol (2011) 0.99
Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun (2010) 0.99
Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis (2009) 0.98
Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98
Determination of target sequence bound by PapX, repressor of bacterial motility, in flhD promoter using systematic evolution of ligands by exponential enrichment (SELEX) and high throughput sequencing. J Biol Chem (2011) 0.96
Vaccines for Proteus mirabilis in urinary tract infection. Int J Antimicrob Agents (2002) 0.96
Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Mol Microbiol (2008) 0.96
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio (2012) 0.95
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun (2008) 0.95
Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection. MBio (2012) 0.94
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect Immun (2009) 0.94
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun (2013) 0.93
Uropathogenic Escherichia coli strains generally lack functional Trg and Tap chemoreceptors found in the majority of E. coli strains strictly residing in the gut. J Bacteriol (2006) 0.92
Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect Immun (2011) 0.91
The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol (2008) 0.91
Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infect Immun (2009) 0.91
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90
Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection. Infect Immun (2008) 0.90
Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J Bacteriol (2008) 0.90
UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Infect Immun (2003) 0.89
Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. J Microbiol Methods (2009) 0.88
Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis (2011) 0.87
Self-transmissibility of the integrative and conjugative element ICEPm1 between clinical isolates requires a functional integrase, relaxase, and type IV secretion system. J Bacteriol (2011) 0.87
Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis. Mol Microbiol (2010) 0.86
Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis. MBio (2012) 0.86
An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol (2009) 0.85
Involvement of mismatch repair in the reciprocal control of motility and adherence of uropathogenic Escherichia coli. Infect Immun (2012) 0.85
Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine. J Bacteriol (2013) 0.85
Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol Spectr (2015) 0.85
Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS. Microbiology (2003) 0.84
Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics (2015) 0.83
The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia. Infect Immun (2011) 0.83
A unique arabinose 5-phosphate isomerase found within a genomic island associated with the uropathogenicity of Escherichia coli CFT073. J Bacteriol (2011) 0.82